Sabra Health Care REIT, Inc. (SBRA) historical REIT analysis and valuation
This 69-page research PDF was generated on August 16, 2026. The HTML summary below exposes key point-in-time report outputs, confidence, evidence alignment, and validation status so readers and retrieval systems can understand the sample without relying on the PDF alone.
| Company | Sabra Health Care REIT, Inc. |
|---|---|
| Ticker | SBRA |
| Report generated | August 16, 2026 |
| Market data as of | 2026-08-16 02:43:50 |
| Report length | 69 pages |
| Validation status | Passed |
Historical valuation snapshot
| Measure | Point-in-time report output | How to read it |
|---|---|---|
| Market price used | $20.32 | Point-in-time market price used by the report. |
| FFO per share | $1.13 | Issuer/report FFO measure shown in the Quick Report. |
| AFFO per share | $1.59 | Issuer-defined AFFO when available. |
| P / FFO | 17.98x | Market price relative to the report's FFO basis. |
| P / AFFO | 12.78x | Market price relative to issuer-defined AFFO when available. |
| Dividend yield | 5.91% | Point-in-time dividend yield shown by the report. |
| Overall model view | Moderately Bullish | Combined report label, not a personalized recommendation. |
| Evidence alignment | Mixed | Whether major report sections pointed in a similar direction. |
| Valuation confidence | Medium The expected price path is Mixed | Input/method confidence, not certainty about future price. |
What the report concluded at that time
, validation status, and links into the complete supporting analysis. Horizon Bear range Base range Bull range Confidence Current $20.32 - $20.32 $20.32 - $20.32 (center $20.32) $20.32 - $20.32 Observed 30 days $14.10 - $17.33 $17.33 - $23.77 (center $20.55) $23.77 - $27.00 Low 90 days $9.52 - $15.19 $15.19 - $26.51 (center $20.85) $26.51 - $32.18 Very Low 180 days $4.87 - $12.96 $12.96 - $29.14 (center $21.05) $29.14 - $37.23 Very Low 365 days $0.00 - $10.65 $10.65 - $32.95 (center $21.30) $32.95 - $44.61 Very Low Bottom line The report's overall REIT outlook is moderately bullish with medium confidence. The best-supported dividend payout ratio is 75.00% of recurring REIT cash earnings. Model View: Moderately Bullish; Evidence Alignment: Mixed; Valuation Confidence: Medium The expected price path is Mixed. Near-term technicals are constructive but not decisive, with price holding above the 200-day EMA while short-term momentum remains choppy.
Why the methods and signals can disagree
Different valuation and research methods answer different questions. Cash-flow, earnings, REIT-specific measures, technical signals, analyst expectations, and qualitative evidence can point in different directions. The report keeps those dimensions separate and exposes confidence and validation findings rather than hiding disagreement inside one number.
What the full report contains
The PDF includes a five-page Quick Report plus the detailed research sections available for that security. Depending on security type and data availability, sections can include company or fund overview, leadership, material developments, financial analysis, valuation, technical analysis, risks, scenarios, charts, sources, validation results, and important disclosures.
Source and freshness limitations
The output reflects public information, market data, calculations, and model assumptions available at the report timestamp. Facts, prices, estimates, and conclusions can become stale immediately. For current research, generate a new report in the app and verify material facts against current primary sources.
Related research workflows: learn how the stock research report generator organizes output, review the DCF valuation workflow, or see how Simple AI Stock Valuation compares with other research platforms.
Generate a fresh report—or research another ticker.
Use Simple AI Stock Valuation to create a new point-in-time research PDF for a supported stock or ETF.
Not investment advice: This historical sample is provided for informational and educational purposes only. It is not a current recommendation, target price, or guarantee. Review the full Important Disclosures and Limitations section inside the PDF.